TASMAR®
Before prescribing TASMAR, the physician should be thoroughly ..... INDICATIONS: TASMAR is indicated as an adjunct to levodopa ...
http://www.valeant.com/fileRepository/products/PI/Tasmar_PI_...
|
TASMAR(R) Kernels/Tablets (100 mg)
TASMAR(R) Kernels/Tablets. (100 mg). Material Safety Data Sheet. 1. Product and Company Identification. Product name. TASMAR(R) Kernels/Tablets (100 mg) ...
http://www.gene.com/gene/products/information/msds/tasmar/MS...
|
Valeant » Products & Pipeline » Neurology » Tasmar®
TASMAR® (tolcapone) is an adjunct oral medication that is used in combination levodopa and carbidopa for patients with severe Parkinson's disease who are ...
http://www.valeant.com/products/neurology/tasmar.jsp...
|
FDA Safety Changes: Comtan, Stalevo, Tasmar, Symmetrel, Xenical ...
22 Apr 2009 ... The FDA has approved safety labeling revisions for entacapone tablets, levodopa/ carbidopa/entacapone tablets, tolcapone tablets, ...
http://www.medscape.com/viewarticle/701711...
|
Tasmar (tolcapone) Tablets February 2009
22 Jun 2009 ... Tasmar (tolcapone) Tablets February 2009. Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...
|
International Approvals: Tasmar, Amplimexon, IV Remodulin
17 Jan 2006 ... Tolcapone (Tasmar) has been reintroduced to the UK market; imexon injection ( Amplimexon) has been granted orphan drug status in Europe; ...
http://www.medscape.com/viewarticle/521699...
|
DailyMed: About DailyMed
Before prescribing TASMAR, the physician should be thoroughly familiar with the ... TASMAR® is available as tablets containing 100 mg or 200 mg tolcapone. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=4387...
|
Tolcapone (Tasmar™)
Tolcapone (Tasmar™). S Robertson. Bureau of Drug Surveillance. Full Text. The Full Text of this article is available as a PDF (159K). ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=12...
|
Tolcapone and hepatotoxic effects. Tasmar Advisory Panel.
Tolcapone and hepatotoxic effects. Tasmar Advisory Panel. Olanow CW. Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA. ...
http://www.ncbi.nlm.nih.gov/pubmed/10681087...
|
/jp'DEPARTMENT OF HEALTH & HUMAN SERVICES
Tasmar was launched in April 1998. This "introducing" claim is misleading because ... Similarly, Tasmar is not a "completely new kind of treatment for ...
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulat...
|
